Viewing Study NCT05024058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-05-23 @ 10:05 AM
Study NCT ID: NCT05024058
Status: TERMINATED
Last Update Posted: 2024-06-18
First Post: 2021-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Inducible Urticaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ligelizumab View
None anti-IgE View
None CINDU View
None chronic inducible urticaria View
None symptomatic dermographism View
None cold urticaria View
None cholinergic urticaria View
None urticaria View
None itch View
None hives View